13K Followers. The session will be held on Wednesday, October 13, 10:00 am - 1:00 pm CT. Im here to listen, and Im here to help.. Advanced Practice Provider Clinical Research Workshop, Clinical Trials Partnerships Update Forum, SWOG NCORP Research Base Clinical Trials Workshop, Take Action Symposium: Hispanic/Latinx Populations, Ensuring Equity in Clinical Research, presented by the SWOG Recruitment and Retention Committee, Early Therapeutics and Rare Cancer Committee, Regulatory 101 & SWOG Perspectives and Common Challenges, Symptom Control and Quality of Life Committee, Palliative and End of Life Care Committee, Pharmaceutical Sciences Committee and Drug Information Subcommittee, Bone Marrow and Stem Cell Transplantation Committee, GU Committee Part I: Prostate; TM; Cancer Control. Or point your camera at the QR code and let your phone do the rest! Dr. Hyngstrom is an Associate Professor in the section of Surgical Oncology, division of General Surgery within the department of Surgery at the University of Utah. Details for the virtual portions of the group meeting will be posted and updated as details are finalized. Faculty and Credentialed Providers | School of Medicine | University of Lack of interferon response in animals to naked siRNAs. SIRPant Immunotherapeutics, Inc., a Biolocity portfolio company, has achieved a significant milestone in the field of immunotherapy. I am actively involved in local, regional, and national groups that focus on improving the treatment for melanoma patients. The Open Forum offers a great opportunity to get answers to your clinical trial questions and to address the science and technical research issues that challenge us today! Diversity, Equity and Inclusion Meet and Greet, Nicholas J. Vogelzang, MD, GU Symposium: Organ Preservation in Bladder Cancer, The Hope Foundations Group Meeting Registration Payment Page, reserve your hotel room at the Hyatt Regency online, https://www.thehopefoundation.org/funding-opportunities/cra-nurse-travel-support-program/, https://www.thehopefoundation.org/group-meetings/committee-group-meeting-funds/, https://www.thehopefoundation.org/funding-opportunities/swog-bog-travel-support/. She is a study chair and translational lead of several cross-NCTN protocols initiated by SWOG, including the immunoMATCH trial. She took a lot of time explaining my situation. She is a Professor in the Department of Surgery at the University of Utah School of Medicine, as well as an Adjunct Professor in the Department of Oncological Sciences. Please view the Exhibitor Prospectus here. We also strongly encourage all attendees to remain masked at all times while indoors in public spaces, in consideration of those around them, and our patients back home. Indicate which topics you wish to attend when registering for the meeting and join us as we continue to learn from the Oishi panelists! Dr. Siwen Hu-Lieskovan is an Associate Professor of Medicine, and Director of Solid Tumor Immunotherapy at the Huntsman Cancer Institute, University of Utah. The cut-off date for making reservations is September 19. He currently serves as the site primary investigator at HCI on multiple therapeutic cooperative group and industry sponsored clinical trials focusing on improving care for patients with advanced melanoma and other solid tumors. -, Internal Medicine Always excellent input on reviewing my scans. The Jeri and Noboru Oishi Symposium will be held on Thursday, October 20, 9:00 am - 12:00 pm CT (check-in begins at 8:30). Gain additional insights from Matt Boron with more PMB information on DTLs, IP accountability, and the Aurora CTEP Inventory management system, etc. -, Hematology/Oncology The Melanoma Research Foundation is a 501(c)(3) non-profit organization. In such circumstances, SWOG will not refund any fees paid to travel to the meeting or hotel fees. If you are unable to attend the SWOG Spring 2023 group meeting in person you may participate virtually. Our Plenary I session will highlight SWOG's translational research in gastrointestinal cancers and will feature an update on our Immunotherapeutics Committee's work on incorporating biomarkers in our immunotherapy trials. United States swog.org Joined January 2012. The Dr spoke directly to me the patient. He is co-director of the physician-lead Clinical Trials Research Group and the clinical lead of the Melanoma Disease Center at HCI. Help Our Cause. We strongly encourage attendees to get the newly updated COVID-19 booster, which better protects against the most recently circulating variant (see CDC recommendation). THE INFORMATION ON THIS WEBSITE IS FOR INFORMATION PURPOSES ONLY AND IS NOT A RECOMMENDATION OR ENDORSEMENT OF ANY DRUG, DEVICE OR TREATMENT OR THAT ANY PARTICULAR DRUG, DEVICE OR TREATMENT IS SAFE, APPROPRIATE OR EFFECTIVE FOR YOU. She was an associate director of the UCLA Parker Institute of Cancer Immunotherapy supervising biobanking and translational studies. Very knowledgable about my case. Internal Medicine - Associate Professor, Divisions: SWOG's Fall 2021 Virtual Group Meeting will take place October 12-16. SWOG Vice Chair for Clinical Trials Partnerships, leads the CTP team. The Hope Foundation provides funding to support travel for member CRAs and nurses to attend the groups annual meetings. Please visit our, If you are unable to travel to the Chicago meeting, or if you cannot or choose not to comply with the vaccination mandate, please join us online for live-streamed sessions. 37 talking about this. He has been an instructor al Healing Mountain Massage School in Salt Lake City since 2016. SWOG is one of five members in the National Cancer Institute's National Clinical Trials Network-the nation's oldest and largest publicly funded cancer research network-and is taking a leadership role in exploring and testing the promise of digital engagement through the empaneling of the Digital Engagement Committee. I see leadership as a service, she says, so Im here to serve everyone. He was instrumental in ensuring they are baked into the original protocol before activation, rather than being added on afterward. Dr. Hu-Lieskovan chairs the SWOG Immunotherapeutics Committee, and is a study chair and translational lead of several cross-NCTN protocols initiated by SWOG, including the immunoMATCH trial. In the past several years, SWOG has expanded its research portfolio to include more studies in Cancer Control and Prevention and Cancer Care Delivery Research under the NCI Community Oncology Research Program (NCORP) umbrella. Speaker/Planner Disclosures (available early October). Please check back often for updates. On-line registration is now open via the registration link below. Speakers and panelists include: Presentations will be followed by a panel discussion with the above presenters and. Deadline to apply: September 14https://www.thehopefoundation.org/group-meetings/committee-group-meeting-funds/. SWOG has members in 47 states and six other countries as part of the NCI's National Clinical Trials Network, or NCTN. NCORP/MU-NCORP Site PI Meeting. PDF Immunotherapeutics Committee - SWOG She has been wonderful. She helped my husband and me understand my future treatments options. EPOCH+/-Rituximab M Fanale 04/13/12 160 No Progress Report Available She is an awesome doctor. Learn more on general IRB management as well as nuances of different IRB requirements as the Oishi panelists continue to discuss the intersection between regulatory and clinical teams. I am honored & happy to be under her care. For this visit most of these questions were irrelevant. The NCORP Research Base Workshop is set for Tuesday, October 12, 12:00 - 2:00 pm. Dr. Hu has is a very caring, knowledgeable, compassionate and empathetic professional that has been displayed in all of my visits. She always explains my treatment plan & answers all my questions. This is an opportunity for information sharing amongst attendees, study chairs, SWOG Data Management staff, the NCI and other subject matter experts. Patients are de-identified for confidentiality and patient privacy. Her research interests include a focus on patient and caregiver quality-of-life issues and on telehealth and technology interventions to improve patient-centered outcomes. The Southwest Oncology Group (SWOG) Statistics & Data Management Center (SDMC), led by Fred Hutch researchers, is responsible for study design and review, data collection and management, randomization procedures, reporting, data analysis and interpretation, data and safety monitoring, quality assurance, training, and computing system development, maintenance and support. She joined the faculty at Vanderbilt-Ingram Cancer Center in July 2019. Ultimately it was my decision. This special perspective is the focus of Site Operations, a subcommittee of the Oncology Research Professionals (ORP) Committee. In such circumstances, SWOG will not refund any fees paid to travel to the meeting or hotel fees. Le Comit Rgional Centre-Val de Loire de Gymnastique compte aujourd'hui plus de 12. Additionally, we are seeking to increase the representation and involvement of Advanced Practice Nurses within SWOG serving as site investigators for DCP studies. Le Pavillon Bleu - a restaurant in the 2023 MICHELIN Guide France. Very good took her time explaining everything extremely polite professional and up front and honest with my diagnosis, Allowing me to be a part of decisions about my care "Excellent! All sessions will be available via online conferencing services. Contact Morgan Cox at The Hope Foundation. I have extensively researched melanoma prevention, early diagnosis, and treatment. A variety of practical topics will be discussed, including: This meeting is open to everyone and provides an opportunity to hear updates and ask questions. Thank you soooo much! Topics for this symposium include: This meeting is open to everyone. Palliative and End of Life Care Committee. She is experienced with protocol development and conduct of immunotherapy-based clinical trials, and has been a principal investigator of industry-, investigator- and cooperative group-initiated clinical trials testing immune checkpoint inhibitors, oncolytic viruses, cancer vaccines and other immune-modulatory agents, as well as cell therapy with genetically modified T cells and hematopoietic stem cells. The meeting is open to Nurse Scientists interested in advancing collaborative research within the clinical trials network as principaland co-investigators and to Nurses interested in serving as Coordinators for studies involving unique orunfamiliar assessments and/or behavioral interventions. April 8 - 13, 2022 Ernest N. Morial Convention Center New Orleans, Louisiana. Failure to provide proof of vaccination will result in the attendee being unable to participate in person at the SWOG conference. Details for the virtual portions of the group meeting will be posted and updated as details are finalized. Homepage | SWOG SWOG disease, research, and administrative committee chairs may request up to $15,000 annually from The Hope Foundation to support committee efforts at meetings that are not currently funded by the NCTN or NCORP grants. Fall 2021 SWOG Virtual Group Meeting | SWOG Very thorough, checked my understanding, very knowledgeable. Oncology Research Professionals and Investigators at NCORP and NCTN institutions. His laboratory studies diverse populations of primary human melanocytes and melanoma cell lines using single cell sequencing, live quantitative phase imaging, and CRISPR/Cas9-based precision engineering. Dr Hu is so amazing. AACR Annual Meeting 2022. Please join us! SWOG Cancer Research Network's Tweets. This is a symposium for all stakeholders -- members of all disciplines are invited! This workshop will address SWOG studies specific to NCORP research areas in: The workshop is for Oncology Research Professionals and Investigators at NCORP and NCTN institutions. Speakersinclude: The theme for the fall general plenary session is "Integrity and Ethical Behavior in Cancer Research." The agenda and topics at each workshop are different each fall and consist, Jeri and Noboru Oishi Symposium & Open Forum. Topics include: 1) understanding Hispanic/Latinx population 2) cancer misinformation 3) cancer health disparities, and 4) best practices for enrolling patients on to clinical trials. This fall's inaugural Nicholas J. Vogelzang, MD, Symposium, to be held Friday, October 21, from 9:30 - 11:30 am CT, will address the topic of organ preservation in bladder cancer. She is a study chair and translational lead of several cross-NCTN protocols initiated by SWOG, including the immunoMATCH trial. She took the necessary time needed to thoroughly explain my diagnosis and answered all of our questions regarding treatment. . She expedited my needed MRI and CT scan, and my first infusion. If you are interested in attending (and are not on our email distribution list), please contact Jamie Myers, Chair, atjmyers@kumc.edu. Immunotherapeutics Committee Monday, April 19, 2021 | 12:30 - 2:30 PM CT Agenda 12:30 - 12:40 Opening Remarks, Mission of the SWOG IO Committee Siwen Hu-Lieskovan, MD, PhD Katerina Politi, PhD 12:40 - 1:10 NCI's Vision on ImmunoMATCH (iMATCH) Helen Chen, MD She is also a consultant on cancer immunotherapy drug development strategies for the pharmaceutical and biotechnology industry. He specializes in neuromuscular release, sports massage, and trigger point release. Join us for the 8th Annual SWOG NCORP Research Base Clinical Trials Workshop on Wednesday, October 19, 12:30 - 4:00 pm CT. SWOG members, TAKE ACTION SYMPOSIUM: Hispanic/Latinx Populations, Ensuring Equity in Clinical Research, SWOG quality assurance topics and questions, The Jeri and Noboru Oishi Symposium will be held on Thursday, October 20, 9:00 am - 12:00 pm. 12:30 - 1:10 pm: Breakout Session 1 (choose one topic below), 1:15 - 2:00 pm: Breakout Session 2 (choose one topic below). Outside of the hospital I enjoy the nature beauty of Utah and spending time with family. I didn't know why I had to drive all that way to see the St for 10 minutes. Speakers and topics: SWOG's fall 2022 general plenary session will take place Friday, October 21, 12:00 - 2:00 pm CT. MATCH Making: NCI's New Precision Medicine Initiative Master Protocols, will feature updates by leaders of the new NCI precision medicine trials, all of which are expected to have component activations this fall: MyeloMATCH, ComboMATCH, and ImmunoMATCH. Melanoma Research Foundation (MRF). Dr. Siwen Hu-Lieskovan is an Associate Professor of Medicine, and Director of Solid Tumor Immunotherapy at the Huntsman Cancer Institute, University of Utah. Funds may be used for invited speakers, special A/V needs, and more. His main clinical focus I diagnosing and treating patients with skin cancer. The scale on which responses are measured is 1 to 5 with 5 being the best score. I feel so good bout her directing my immunotherapy treatments! Dr. Dizon is currently chair of SWOG's digital engagement committee. ORP Open Forum Breakout Session 1 (choose one topic below): ORP Open Forum Breakout Session 2 (choose one topic below): Myeloma Working Group (Working Group Members Only), ORP Liaison Subcommittee (Committee Members Only), Lymphoma Working Group (Working Group Members Only), Lung Working Group (Working Group Members Only), Conflict Management Committee (Committee Members Only), Imaging Committee (Committee Members Only), Professional Review Committee (Committee Members Only), SWOG Data and Safety Monitoring Committee (Committee Members Only), GI Working Group (Working Group Members Only), Breast Working Group (Working Group Members Only), Melanoma Working Group (Working Group Members Only), Quality Assurance Committee (Committee Members Only), Publications Committee (Committee Members Only), Leukemia Working Group (Working Group Members Only), Breast Translational Medicine Working Group (Working Group Members Only), ORP Executive Committee (Committee Members Only), Committee Chairs Meeting (Committee Chairs Only). Grossman received his MD and PhD from Baylor College of Medicine, completed an internship at Yale-New Haven Hospital, and completed a dermatology residency at Yale. I have been impressed by Dr. Hu-Lieskovan's preparation for each visit along with the follow-through of her and the other team members each time that treatment plan changes have been necessary. LinkedIn; Twitter; YouTube Im extremely grateful to Dr. Lyman for his service to SWOG and thank him for his willingness to continue serving as a senior advisor. Join us for the 8th Annual SWOG NCORP Research Base Clinical Trials Workshop on Wednesday, October 19, 12:30 - 4:00 pm CT. SWOG members, clinical research professionals and investigators at NCTN and NCORP institutions are encouraged to attend the informative presentations and panel discussions. -, Pathology Hear real-life lessons and downstream effects from the Oishi panelists as we continue the conversation of challenges in the ever-changing research environment. For closed meetings, call-in details will not be available on the site but emailed to participants separately. I completed my Surgical Oncology training at MD Anderson Cancer Center in Houston, Texas. For open meetings, Zoom details will be available on the microsite and is also included in the new "Add to Calendar" feature. This will be an informative symposium you won't want to miss! Hes graciously agreed to serve as senior advisor to me on these MATCH trials, both of which are expected to activate protocols (or pilots) before the year is out. Siwen is a member of the NCI Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force, Society of ImmunoTherapy of Cancer (SITC) Biomarker Taskforce, ASCO, and AACR. (, :We look forward to your participation at the, SWOG Virtual Group Meeting! Dr. Hu-Lieskovan's expertise allows me to have quality of life as I travel thru this Melanoma journey. His medical practice is in general surgical oncology with a focus on melanoma and sarcoma, treating patients at the Huntsman Cancer Institute. . The summer 2023 issue of the Lung-MAP Newsletter is now available! SWOG Clinical Trials Partnerships is how SWOG Cancer Research Network partners with the industry to conduct cancer clinical trials. This symposium is sponsored by the SWOG Nursing Research Subcommittee and Palliative and End of Life Care Committee, and is funded by The Hope Foundation. APRIL 26 - 29, 2017 SWOG LYMPHOMA 5 Non-SWOG Studies with SWOG-Credited Registrations LYMPHOMA COMMITTEE Studies with Accrual from July 2015 - December 2016 SWOG Champion Date Activated Date Closed Total Accrual 9177 NHL, Dose-adj. We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. SWOG Spring 2022 Hybrid Group Meeting: Immunotherapeutics Committee Hes graciously agreed to serve as senior advisor to me on these MATCH trials, both of which are expected to activate protocols (or pilots) before the year is out. In keeping with best practices at meetings of medical professionals, Failure to provide proof of vaccination will result in the attendee being unable to participate in person at the SWOG conference. QUESTIONS REGARDING ANY DRUG, DEVICE OR TREATMENT SHOULD BE DIRECTED TO YOUR HEALTHCARE PROVIDER. Both the intrinsic transcriptional and epigenetic programs as well as the external environmental and chemical factors that govern the probability of transformation are poorly understood. Melanomas are derived from melanocytes that have acquired specific genetic mutations. First time seeing Dr. Hu-Lieskovan & she exceeded my expectations! Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma Dr. Siwen Hu-Lieskovan is an Associate Professor of Medicine, and Director of Solid Tumor Immunotherapy at the Huntsman Cancer Institute, University of Utah. She is also a consultant on cancer immunotherapy drug development strategies for the pharmaceutical and biotechnology industry. In the past, she and her research teams made contributions in understanding the role of driver mutations in oncogenesis and immune evasion, mechanisms of response and resistance to immune checkpoint inhibitors, and developing novel drug delivery systems. Fall 2021 GM Immunotherapeutics Committee Session Summary | SWOG Happily for SWOG, hell continue his involvement with the immunotherapeutics committee and the ImmunoMATCH and ComboMATCH studies (including his role on the latter trials steering committee). The group meeting site for accessing all meeting agendas and call-in details can be found here: . Diversity, Equity, and Inclusion for All - The Hope Foundation During his residency, he completed a two-year clinical research fellowship in surgical oncology and tumor immunology at the Surgery Branch of the NCI/NIH in Bethesda, Maryland. Response to programmed cell death-1 blockade in a murine melanoma syngeneic model requires costimulation, CD4, and CD8 T cells. Dr. Hu was so helpful in explaining my condition, treatment options and possible side effects, etc. The agenda and topics at each workshop are different each fall and consistof didactic presentations. Sheri Holmen, PhD, is a Huntsman Cancer Institute (HCI) investigator and Co-Director of the Melanoma Disease Oriented Research Team (MDOT). Plenary II (General) Radiation Oncology Committee. Selective usage of D type cyclins by Ewing's tumors and rhabdomyosarcomas. (morgan@thehopefoundation.org). Once you submit your registration, you will have the option to add your schedule to your calendar. Deadline to apply: September 10https://www.thehopefoundation.org/group-meetings/committee-group-meeting-funds/Questions? SWOG member benefits include . Fall 2022 SWOG Group Meeting | SWOG She was very knowledgeable and professional. She is a board-certified oncologist with clinical focus on melanoma/skin cancers and early phase testing of cancer immunotherapies in solid tumors. Join SWOG Cancer Research Network | SWOG Comit Rgional d'Escrime du Centre-Val de Loire, Olivet, Centre, France. Forte de ses 25 clubs, de ses 37 enseignants et ducateurs, et de 1828 licencis (au 20/12/2016), le Comit. Dr. Hu-Lieskovans laboratory uses cutting-edge technologies to investigate mechanisms of resistance to immunotherapy, develop novel combination strategies to overcome resistance, improve efficacy, as well as monitor and prevent immunotherapy-induced toxicities. Remote attendees and presenters can access call links for open sessions on our, Please note: SWOG has updated the registration policy to ensure we can maintain meetings of the highest caliber. She is experienced with protocol development and conduct of immunotherapy-based clinical trials, and has been a principal investigator of industry-, investigator- and cooperative group-initiated clinical trials testing immune checkpoint inhibitors, oncolytic viruses, cancer vaccines and other immune-modulatory agents, as well as cell therapy with genetically modified T cells and hematopoietic stem cells. Abstracts | AACR Annual Meeting 2022 As a member of SWOG, I am the Vice-Chair of the. The MICHELIN inspectors' point of view, information on prices, types of cuisine and opening hours on the MICHELIN Guide's official website (Photo by Zhifei Zhou) Posted on February 25, 2022 under Group Meetings. Siwen is a member of the NCI Investigational Drug Steering Committee (IDSC) Immunotherapy Task Force, Society of ImmunoTherapy of Cancer (SITC) Biomarker Taskforce, ASCO, and AACR. For Group Meeting questions not answered here, you can send us a message via theContact Uspage. Dr. Hu-Lieskovan chairs the SWOG Immunotherapeutics Committee, and is a study chair and translational lead of several cross-NCTN protocols initiated by SWOG, including the immunoMATCH trial. She has been a scientific advisor on cancer immunotherapy drug development strategies for the pharmaceutical and biotechnology industry. Cathy Eng - Director for Strategic Relations - LinkedIn Deadline to request support: September 14https://www.thehopefoundation.org/funding-opportunities/swog-bog-travel-support/. The committee is a subcommittee of the Oncology Research Professionals (ORP) Committee, and this meeting covers a variety of practical and operational topics including: This meeting is open to everyone and provides an opportunity to hear updates and ask questions. Additionally, we are seeking to increase the representation and involvement of Advanced Practice Nurses within SWOG serving as site investigators for DCP studies. SIRPant Immunotherapeutics, Inc. received FDA clearance and IND We sincerely appreciated her explanations, personal perspective, and true concern for my diagnosis. As with our spring meeting, attendees must provide proof of full vaccination, to gain entry to the meeting. Honoring the many valuable contributions Dr. Vogelzang hasmade in support of his colleagues and patients throughouthis career within SWOGs research network,Vogelzang symposia are held at SWOG group meetings toprovide members with the latest and best resources forextending and improving the lives of those impacted bygenitourinary cancers. She knew every detail of my previous treatments & presented a plan for future treatment with care & making sure I understood all the details of the plan & how the cancer treatment worked. The doctor was absolutely fantastic! Fall 2021 GM Immunotherapeutics Committee Session Summary Download your summary as a Word document.. Footer: Social Links. Immunotherapeutics Committee Wednesday, April 6, 2022 4:30 PM - 6:30 PM PT 4:30 - 4:35 PM Welcome and Introductions Katie Politi & Siwen Hu-Lieskovan 4:35 - 5:05 PM Identification of Genes Uniquely Contributing to Check point Blockade Induced Immune Related Advers Events David Serreze, Phd Professor, The Jackson Laboratory The lectureship brings a special guest speaker to SWOG group meetings, alternating between a focus on lung and breast cancer advances in translational medicine. She was so engaged with my care & really listened to & answered all my questions. Current efforts utilize a genetic approach to address this question in tumors that are generally refractory to conventional therapies, including metastatic melanoma and glioblastoma.